OnKure Therapeutics, Inc. — Director's Dealing 2021

Jul 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Reneo Pharmaceuticals, Inc. (RPHM)
CIK: 0001637715
Period of Report: 2021-07-08

Reporting Person: Johnson Wendy S. (Chief Development Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-08	Common Stock	M	111736	$1.97	Acquired	111736	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-08	Stock option (right to buy)	$1.97	M	111736	Disposed	2028-04-04	Common Stock (111736)	Direct